MTOR and skin basal cell carcinoma: Thus, while blocking mTOR may take away a signaling component that is necessary but not sufficient for transformation, the mTOR and HH pathways coincidentally may target an overlapping set of genes that are likely to inhibit BCC carcinogenesis.